Paxman AB Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Paxman AB cash flow conversion efficiency. Based on the latest financial reports, Paxman AB (PAX) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.98 Million ≈ $-643.87K USD) by net assets (Skr427.76 Million ≈ $46.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Paxman AB (2017–2024)

Cash flow conversion efficiency of Paxman AB from 2017 to 2024. This chart illustrates how Paxman AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Paxman AB for real-time trading data and today's change.

Paxman AB Cash Flow Conversion Ratio Explained

Paxman AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Paxman AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Paxman AB ranked by their cash flow conversion efficiency. Also see PAX market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Inission AB (publ) ST:INISS-B	0.058x
Rugvista Group AB ST:RUG	0.006x
Gesher Acquisition Corp. II NASDAQ:GSHR	-0.001x
American Bitcoin Corp NASDAQ:ABTC	-0.032x
Acme United Corporation NYSE MKT:ACU	-0.019x
UNISEM Co. Ltd KQ:036200	0.022x
San Far Property Ltd TW:9946	0.166x
Summit Securities Limited NSE:SUMMITSEC	0.011x

Annual Cash Flow Conversion Efficiency for Paxman AB (2017–2024)

The table below shows the annual cash flow conversion efficiency of Paxman AB from 2017 to 2024. Review Paxman AB (PAX) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr163.99 Million ≈ $17.65 Million	Skr39.10 Million ≈ $4.21 Million	0.238x	+87.04%
2023-12-31	Skr122.62 Million ≈ $13.20 Million	Skr15.63 Million ≈ $1.68 Million	0.127x	+442.03%
2022-12-31	Skr114.20 Million ≈ $12.29 Million	Skr2.69 Million ≈ $289.06K	0.024x	+171.39%
2021-12-31	Skr125.75 Million ≈ $13.53 Million	Skr-4.14 Million ≈ $-445.85K	-0.033x	+95.77%
2020-12-31	Skr10.89 Million ≈ $1.17 Million	Skr-8.48 Million ≈ $-913.01K	-0.779x	-768.59%
2019-12-31	Skr28.36 Million ≈ $3.05 Million	Skr3.31 Million ≈ $355.67K	0.117x	+639.81%
2018-12-31	Skr25.39 Million ≈ $2.73 Million	Skr400.00K ≈ $43.05K	0.016x	+107.24%
2017-12-31	Skr32.77 Million ≈ $3.53 Million	Skr-7.13 Million ≈ $-767.62K	-0.218x	--

About Paxman AB

ST:PAX Sweden Medical Devices

Market Cap

$158.54 Million

Skr1.47 Billion SEK

Market Cap Rank

#17244 Global

#293 in Sweden

Share Price

Skr63.30

Change (1 day)

-0.78%

52-Week Range

Skr43.55 - Skr68.40

All Time High

Skr83.80